nodes	percent_of_prediction	percent_of_DWPC	metapath
Hexobarbital—CHRNA4—attention deficit hyperactivity disorder	0.779	1	CbGaD
Hexobarbital—CHRNA4—autonomic nervous system—attention deficit hyperactivity disorder	0.00762	0.0942	CbGeAlD
Hexobarbital—Heptabarbital—CHRNA4—attention deficit hyperactivity disorder	0.00336	0.57	CrCbGaD
Hexobarbital—Methylphenobarbital—CHRNA4—attention deficit hyperactivity disorder	0.00253	0.43	CrCbGaD
Hexobarbital—GRIA2—forebrain—attention deficit hyperactivity disorder	0.00245	0.0302	CbGeAlD
Hexobarbital—GABRA5—forebrain—attention deficit hyperactivity disorder	0.00229	0.0283	CbGeAlD
Hexobarbital—CHRFAM7A—forebrain—attention deficit hyperactivity disorder	0.00223	0.0276	CbGeAlD
Hexobarbital—GRIK2—forebrain—attention deficit hyperactivity disorder	0.00221	0.0273	CbGeAlD
Hexobarbital—GABRA4—forebrain—attention deficit hyperactivity disorder	0.00208	0.0257	CbGeAlD
Hexobarbital—CHRNA7—forebrain—attention deficit hyperactivity disorder	0.0018	0.0223	CbGeAlD
Hexobarbital—CHRNA4—forebrain—attention deficit hyperactivity disorder	0.00178	0.022	CbGeAlD
Hexobarbital—GRIA2—midbrain—attention deficit hyperactivity disorder	0.00162	0.02	CbGeAlD
Hexobarbital—GABRA2—forebrain—attention deficit hyperactivity disorder	0.00159	0.0197	CbGeAlD
Hexobarbital—GABRA1—forebrain—attention deficit hyperactivity disorder	0.00154	0.019	CbGeAlD
Hexobarbital—CHRNA7—cardiovascular system—attention deficit hyperactivity disorder	0.00152	0.0188	CbGeAlD
Hexobarbital—CHRNA4—cardiovascular system—attention deficit hyperactivity disorder	0.0015	0.0186	CbGeAlD
Hexobarbital—GRIK2—midbrain—attention deficit hyperactivity disorder	0.00146	0.018	CbGeAlD
Hexobarbital—GRIA2—nervous system—attention deficit hyperactivity disorder	0.00133	0.0164	CbGeAlD
Hexobarbital—GABRA6—nervous system—attention deficit hyperactivity disorder	0.00128	0.0159	CbGeAlD
Hexobarbital—GRIA2—central nervous system—attention deficit hyperactivity disorder	0.00128	0.0158	CbGeAlD
Hexobarbital—GRIA2—cerebellum—attention deficit hyperactivity disorder	0.00125	0.0154	CbGeAlD
Hexobarbital—GABRA5—nervous system—attention deficit hyperactivity disorder	0.00124	0.0154	CbGeAlD
Hexobarbital—GABRA6—central nervous system—attention deficit hyperactivity disorder	0.00124	0.0153	CbGeAlD
Hexobarbital—CHRFAM7A—nervous system—attention deficit hyperactivity disorder	0.00121	0.015	CbGeAlD
Hexobarbital—GABRA6—cerebellum—attention deficit hyperactivity disorder	0.00121	0.0149	CbGeAlD
Hexobarbital—GRIK2—nervous system—attention deficit hyperactivity disorder	0.0012	0.0148	CbGeAlD
Hexobarbital—GABRA5—central nervous system—attention deficit hyperactivity disorder	0.0012	0.0148	CbGeAlD
Hexobarbital—CHRNA4—midbrain—attention deficit hyperactivity disorder	0.00117	0.0145	CbGeAlD
Hexobarbital—CHRFAM7A—central nervous system—attention deficit hyperactivity disorder	0.00117	0.0144	CbGeAlD
Hexobarbital—GABRA3—nervous system—attention deficit hyperactivity disorder	0.00116	0.0143	CbGeAlD
Hexobarbital—GRIK2—central nervous system—attention deficit hyperactivity disorder	0.00116	0.0143	CbGeAlD
Hexobarbital—GABRA4—nervous system—attention deficit hyperactivity disorder	0.00113	0.014	CbGeAlD
Hexobarbital—GRIK2—cerebellum—attention deficit hyperactivity disorder	0.00113	0.014	CbGeAlD
Hexobarbital—GABRA3—central nervous system—attention deficit hyperactivity disorder	0.00112	0.0138	CbGeAlD
Hexobarbital—GABRA4—central nervous system—attention deficit hyperactivity disorder	0.00109	0.0134	CbGeAlD
Hexobarbital—GABRA4—cerebellum—attention deficit hyperactivity disorder	0.00106	0.0131	CbGeAlD
Hexobarbital—GRIA2—brain—attention deficit hyperactivity disorder	0.00102	0.0125	CbGeAlD
Hexobarbital—GABRA1—midbrain—attention deficit hyperactivity disorder	0.00101	0.0125	CbGeAlD
Hexobarbital—GABRA6—brain—attention deficit hyperactivity disorder	0.000981	0.0121	CbGeAlD
Hexobarbital—CHRNA7—nervous system—attention deficit hyperactivity disorder	0.000978	0.0121	CbGeAlD
Hexobarbital—CHRNA4—nervous system—attention deficit hyperactivity disorder	0.000964	0.0119	CbGeAlD
Hexobarbital—GABRA5—brain—attention deficit hyperactivity disorder	0.000952	0.0118	CbGeAlD
Hexobarbital—CHRNA7—central nervous system—attention deficit hyperactivity disorder	0.000941	0.0116	CbGeAlD
Hexobarbital—CHRNA4—central nervous system—attention deficit hyperactivity disorder	0.000928	0.0115	CbGeAlD
Hexobarbital—CHRFAM7A—brain—attention deficit hyperactivity disorder	0.000925	0.0114	CbGeAlD
Hexobarbital—GRIK2—brain—attention deficit hyperactivity disorder	0.000917	0.0113	CbGeAlD
Hexobarbital—CHRNA4—cerebellum—attention deficit hyperactivity disorder	0.000907	0.0112	CbGeAlD
Hexobarbital—GABRA3—brain—attention deficit hyperactivity disorder	0.000886	0.0109	CbGeAlD
Hexobarbital—GABRA4—brain—attention deficit hyperactivity disorder	0.000863	0.0107	CbGeAlD
Hexobarbital—GABRA2—nervous system—attention deficit hyperactivity disorder	0.000863	0.0107	CbGeAlD
Hexobarbital—GABRA1—nervous system—attention deficit hyperactivity disorder	0.000834	0.0103	CbGeAlD
Hexobarbital—GABRA2—central nervous system—attention deficit hyperactivity disorder	0.000831	0.0103	CbGeAlD
Hexobarbital—PTGS1—forebrain—attention deficit hyperactivity disorder	0.000819	0.0101	CbGeAlD
Hexobarbital—GABRA2—cerebellum—attention deficit hyperactivity disorder	0.000812	0.01	CbGeAlD
Hexobarbital—GABRA1—central nervous system—attention deficit hyperactivity disorder	0.000803	0.00993	CbGeAlD
Hexobarbital—GABRA1—cerebellum—attention deficit hyperactivity disorder	0.000785	0.0097	CbGeAlD
Hexobarbital—CYP2C9—cardiovascular system—attention deficit hyperactivity disorder	0.000759	0.00938	CbGeAlD
Hexobarbital—CHRNA7—brain—attention deficit hyperactivity disorder	0.000747	0.00923	CbGeAlD
Hexobarbital—CHRNA4—brain—attention deficit hyperactivity disorder	0.000737	0.00911	CbGeAlD
Hexobarbital—CYP2E1—cardiovascular system—attention deficit hyperactivity disorder	0.000719	0.00889	CbGeAlD
Hexobarbital—PTGS1—cardiovascular system—attention deficit hyperactivity disorder	0.000693	0.00856	CbGeAlD
Hexobarbital—GABRA2—brain—attention deficit hyperactivity disorder	0.00066	0.00815	CbGeAlD
Hexobarbital—GABRA1—brain—attention deficit hyperactivity disorder	0.000638	0.00788	CbGeAlD
Hexobarbital—CYP2E1—nervous system—attention deficit hyperactivity disorder	0.000462	0.0057	CbGeAlD
Hexobarbital—PTGS1—nervous system—attention deficit hyperactivity disorder	0.000445	0.0055	CbGeAlD
Hexobarbital—CYP2E1—central nervous system—attention deficit hyperactivity disorder	0.000444	0.00549	CbGeAlD
Hexobarbital—CYP2E1—cerebellum—attention deficit hyperactivity disorder	0.000434	0.00537	CbGeAlD
Hexobarbital—PTGS1—central nervous system—attention deficit hyperactivity disorder	0.000428	0.00529	CbGeAlD
Hexobarbital—CYP3A4—nervous system—attention deficit hyperactivity disorder	0.000371	0.00459	CbGeAlD
Hexobarbital—CYP3A4—central nervous system—attention deficit hyperactivity disorder	0.000358	0.00442	CbGeAlD
Hexobarbital—CYP2E1—brain—attention deficit hyperactivity disorder	0.000353	0.00436	CbGeAlD
Hexobarbital—GRIA2—Transmission across Chemical Synapses—CACNB2—attention deficit hyperactivity disorder	0.000344	0.00257	CbGpPWpGaD
Hexobarbital—CYP1A2—Estrogen metabolism—COMT—attention deficit hyperactivity disorder	0.000344	0.00257	CbGpPWpGaD
Hexobarbital—PTGS1—brain—attention deficit hyperactivity disorder	0.00034	0.0042	CbGeAlD
Hexobarbital—CHRNA4—Transmission across Chemical Synapses—CACNB2—attention deficit hyperactivity disorder	0.000334	0.00249	CbGpPWpGaD
Hexobarbital—GABRA6—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA4—attention deficit hyperactivity disorder	0.000328	0.00244	CbGpPWpGaD
Hexobarbital—CHRNA7—Transmission across Chemical Synapses—SNAP25—attention deficit hyperactivity disorder	0.000328	0.00244	CbGpPWpGaD
Hexobarbital—CHRNA4—SIDS Susceptibility Pathways—SLC6A4—attention deficit hyperactivity disorder	0.000326	0.00243	CbGpPWpGaD
Hexobarbital—CHRNA4—SIDS Susceptibility Pathways—SNAP25—attention deficit hyperactivity disorder	0.000326	0.00243	CbGpPWpGaD
Hexobarbital—GABRA4—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA4—attention deficit hyperactivity disorder	0.000323	0.00241	CbGpPWpGaD
Hexobarbital—GRIK2—Transmission across Chemical Synapses—SLC6A3—attention deficit hyperactivity disorder	0.000321	0.00239	CbGpPWpGaD
Hexobarbital—CHRNA7—Neuronal System—CACNB2—attention deficit hyperactivity disorder	0.000314	0.00234	CbGpPWpGaD
Hexobarbital—GABRA1—Neuronal System—GABRQ—attention deficit hyperactivity disorder	0.000309	0.00231	CbGpPWpGaD
Hexobarbital—CHRNA7—SIDS Susceptibility Pathways—MAOA—attention deficit hyperactivity disorder	0.000301	0.00224	CbGpPWpGaD
Hexobarbital—CYP2C19—Melatonin metabolism and effects—MAOA—attention deficit hyperactivity disorder	0.0003	0.00224	CbGpPWpGaD
Hexobarbital—GRIK2—Neuronal System—CHRNA4—attention deficit hyperactivity disorder	0.000297	0.00221	CbGpPWpGaD
Hexobarbital—GRIA2—Transmission across Chemical Synapses—CHRNA4—attention deficit hyperactivity disorder	0.000296	0.00221	CbGpPWpGaD
Hexobarbital—CHRNA7—Transmission across Chemical Synapses—SLC6A3—attention deficit hyperactivity disorder	0.000292	0.00218	CbGpPWpGaD
Hexobarbital—CHRNA7—SIDS Susceptibility Pathways—BDNF—attention deficit hyperactivity disorder	0.00029	0.00216	CbGpPWpGaD
Hexobarbital—GABRA5—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA4—attention deficit hyperactivity disorder	0.000287	0.00214	CbGpPWpGaD
Hexobarbital—GABRA6—Transmission across Chemical Synapses—CACNB2—attention deficit hyperactivity disorder	0.000286	0.00214	CbGpPWpGaD
Hexobarbital—GABRA4—Transmission across Chemical Synapses—CACNB2—attention deficit hyperactivity disorder	0.000283	0.00211	CbGpPWpGaD
Hexobarbital—GABRA3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA4—attention deficit hyperactivity disorder	0.000282	0.00211	CbGpPWpGaD
Hexobarbital—GABRA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA4—attention deficit hyperactivity disorder	0.000277	0.00207	CbGpPWpGaD
Hexobarbital—GRIK2—Neuronal System—SNAP25—attention deficit hyperactivity disorder	0.000276	0.00206	CbGpPWpGaD
Hexobarbital—GRIA2—Transmission across Chemical Synapses—SNAP25—attention deficit hyperactivity disorder	0.000275	0.00205	CbGpPWpGaD
Hexobarbital—GRIK2—Transmission across Chemical Synapses—COMT—attention deficit hyperactivity disorder	0.000273	0.00204	CbGpPWpGaD
Hexobarbital—GRIK2—Transmission across Chemical Synapses—MAOA—attention deficit hyperactivity disorder	0.000271	0.00202	CbGpPWpGaD
Hexobarbital—CHRNA7—Neuronal System—CHRNA4—attention deficit hyperactivity disorder	0.00027	0.00201	CbGpPWpGaD
Hexobarbital—CHRNA4—Transmission across Chemical Synapses—SNAP25—attention deficit hyperactivity disorder	0.000267	0.00199	CbGpPWpGaD
Hexobarbital—CYP3A4—Estrogen metabolism—COMT—attention deficit hyperactivity disorder	0.000266	0.00198	CbGpPWpGaD
Hexobarbital—GRIA2—Neuronal System—CACNB2—attention deficit hyperactivity disorder	0.000264	0.00197	CbGpPWpGaD
Hexobarbital—GRIA2—BDNF signaling pathway—BDNF—attention deficit hyperactivity disorder	0.00026	0.00194	CbGpPWpGaD
Hexobarbital—CHRNA4—Neuronal System—CACNB2—attention deficit hyperactivity disorder	0.000256	0.00191	CbGpPWpGaD
Hexobarbital—GABRA1—SIDS Susceptibility Pathways—TPH2—attention deficit hyperactivity disorder	0.000252	0.00188	CbGpPWpGaD
Hexobarbital—GABRA5—Transmission across Chemical Synapses—CACNB2—attention deficit hyperactivity disorder	0.000251	0.00187	CbGpPWpGaD
Hexobarbital—CHRNA7—Neuronal System—SNAP25—attention deficit hyperactivity disorder	0.000251	0.00187	CbGpPWpGaD
Hexobarbital—CHRNA7—Transmission across Chemical Synapses—COMT—attention deficit hyperactivity disorder	0.000248	0.00185	CbGpPWpGaD
Hexobarbital—GABRA3—Transmission across Chemical Synapses—CACNB2—attention deficit hyperactivity disorder	0.000247	0.00184	CbGpPWpGaD
Hexobarbital—CHRNA7—Transmission across Chemical Synapses—MAOA—attention deficit hyperactivity disorder	0.000246	0.00184	CbGpPWpGaD
Hexobarbital—GABRA6—Transmission across Chemical Synapses—CHRNA4—attention deficit hyperactivity disorder	0.000246	0.00184	CbGpPWpGaD
Hexobarbital—GRIK2—Neuronal System—SLC6A3—attention deficit hyperactivity disorder	0.000246	0.00183	CbGpPWpGaD
Hexobarbital—GRIA2—Transmission across Chemical Synapses—SLC6A3—attention deficit hyperactivity disorder	0.000245	0.00183	CbGpPWpGaD
Hexobarbital—CHRNA7—SIDS Susceptibility Pathways—HTR2A—attention deficit hyperactivity disorder	0.000245	0.00183	CbGpPWpGaD
Hexobarbital—CHRNA4—SIDS Susceptibility Pathways—MAOA—attention deficit hyperactivity disorder	0.000245	0.00183	CbGpPWpGaD
Hexobarbital—GABRA4—Transmission across Chemical Synapses—CHRNA4—attention deficit hyperactivity disorder	0.000243	0.00181	CbGpPWpGaD
Hexobarbital—GABRA2—Transmission across Chemical Synapses—CACNB2—attention deficit hyperactivity disorder	0.000242	0.00181	CbGpPWpGaD
Hexobarbital—GABRA6—Transmembrane transport of small molecules—SLC9A9—attention deficit hyperactivity disorder	0.000242	0.0018	CbGpPWpGaD
Hexobarbital—GABRA4—Transmembrane transport of small molecules—SLC9A9—attention deficit hyperactivity disorder	0.000239	0.00178	CbGpPWpGaD
Hexobarbital—CHRNA4—Transmission across Chemical Synapses—SLC6A3—attention deficit hyperactivity disorder	0.000238	0.00178	CbGpPWpGaD
Hexobarbital—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA4—attention deficit hyperactivity disorder	0.000237	0.00176	CbGpPWpGaD
Hexobarbital—CHRNA4—SIDS Susceptibility Pathways—BDNF—attention deficit hyperactivity disorder	0.000236	0.00176	CbGpPWpGaD
Hexobarbital—PTGS1—Phase 1 - Functionalization of compounds—MAOA—attention deficit hyperactivity disorder	0.000235	0.00176	CbGpPWpGaD
Hexobarbital—CYP1A2—Melatonin metabolism and effects—MAOA—attention deficit hyperactivity disorder	0.000233	0.00174	CbGpPWpGaD
Hexobarbital—GABRA6—Transmembrane transport of small molecules—GABRQ—attention deficit hyperactivity disorder	0.00023	0.00172	CbGpPWpGaD
Hexobarbital—GABRA6—Transmission across Chemical Synapses—SNAP25—attention deficit hyperactivity disorder	0.000229	0.00171	CbGpPWpGaD
Hexobarbital—GABRA4—Transmembrane transport of small molecules—GABRQ—attention deficit hyperactivity disorder	0.000228	0.0017	CbGpPWpGaD
Hexobarbital—GRIA2—Neuronal System—CHRNA4—attention deficit hyperactivity disorder	0.000227	0.00169	CbGpPWpGaD
Hexobarbital—GABRA4—Transmission across Chemical Synapses—SNAP25—attention deficit hyperactivity disorder	0.000226	0.00169	CbGpPWpGaD
Hexobarbital—CHRNA7—Neuronal System—SLC6A3—attention deficit hyperactivity disorder	0.000224	0.00167	CbGpPWpGaD
Hexobarbital—GABRA6—Neuronal System—CACNB2—attention deficit hyperactivity disorder	0.000219	0.00164	CbGpPWpGaD
Hexobarbital—GABRA1—SIDS Susceptibility Pathways—CHRNA4—attention deficit hyperactivity disorder	0.000217	0.00162	CbGpPWpGaD
Hexobarbital—GABRA4—Neuronal System—CACNB2—attention deficit hyperactivity disorder	0.000217	0.00162	CbGpPWpGaD
Hexobarbital—GABRA5—Transmission across Chemical Synapses—CHRNA4—attention deficit hyperactivity disorder	0.000216	0.00161	CbGpPWpGaD
Hexobarbital—GABRA3—Transmission across Chemical Synapses—CHRNA4—attention deficit hyperactivity disorder	0.000212	0.00158	CbGpPWpGaD
Hexobarbital—GABRA5—Transmembrane transport of small molecules—SLC9A9—attention deficit hyperactivity disorder	0.000212	0.00158	CbGpPWpGaD
Hexobarbital—GRIA2—Neuronal System—SNAP25—attention deficit hyperactivity disorder	0.000211	0.00157	CbGpPWpGaD
Hexobarbital—GRIK2—Neuronal System—COMT—attention deficit hyperactivity disorder	0.000209	0.00156	CbGpPWpGaD
Hexobarbital—GRIA2—Transmission across Chemical Synapses—COMT—attention deficit hyperactivity disorder	0.000209	0.00156	CbGpPWpGaD
Hexobarbital—GABRA2—Transmission across Chemical Synapses—CHRNA4—attention deficit hyperactivity disorder	0.000209	0.00156	CbGpPWpGaD
Hexobarbital—GABRA3—Transmembrane transport of small molecules—SLC9A9—attention deficit hyperactivity disorder	0.000208	0.00155	CbGpPWpGaD
Hexobarbital—GRIK2—Neuronal System—MAOA—attention deficit hyperactivity disorder	0.000208	0.00155	CbGpPWpGaD
Hexobarbital—GRIA2—Transmission across Chemical Synapses—MAOA—attention deficit hyperactivity disorder	0.000207	0.00155	CbGpPWpGaD
Hexobarbital—GABRA1—Transmission across Chemical Synapses—CACNB2—attention deficit hyperactivity disorder	0.000207	0.00154	CbGpPWpGaD
Hexobarbital—CHRNA4—Neuronal System—SNAP25—attention deficit hyperactivity disorder	0.000205	0.00153	CbGpPWpGaD
Hexobarbital—GABRA2—Transmembrane transport of small molecules—SLC9A9—attention deficit hyperactivity disorder	0.000205	0.00153	CbGpPWpGaD
Hexobarbital—GABRA6—Transmission across Chemical Synapses—SLC6A3—attention deficit hyperactivity disorder	0.000204	0.00152	CbGpPWpGaD
Hexobarbital—CHRNA4—Transmission across Chemical Synapses—COMT—attention deficit hyperactivity disorder	0.000202	0.00151	CbGpPWpGaD
Hexobarbital—GABRA5—Transmembrane transport of small molecules—GABRQ—attention deficit hyperactivity disorder	0.000202	0.00151	CbGpPWpGaD
Hexobarbital—GABRA1—SIDS Susceptibility Pathways—SNAP25—attention deficit hyperactivity disorder	0.000202	0.0015	CbGpPWpGaD
Hexobarbital—GABRA1—SIDS Susceptibility Pathways—SLC6A4—attention deficit hyperactivity disorder	0.000202	0.0015	CbGpPWpGaD
Hexobarbital—GABRA4—Transmission across Chemical Synapses—SLC6A3—attention deficit hyperactivity disorder	0.000202	0.0015	CbGpPWpGaD
Hexobarbital—CHRNA4—Transmission across Chemical Synapses—MAOA—attention deficit hyperactivity disorder	0.000201	0.0015	CbGpPWpGaD
Hexobarbital—GABRA5—Transmission across Chemical Synapses—SNAP25—attention deficit hyperactivity disorder	0.000201	0.0015	CbGpPWpGaD
Hexobarbital—CHRNA4—SIDS Susceptibility Pathways—HTR2A—attention deficit hyperactivity disorder	0.0002	0.00149	CbGpPWpGaD
Hexobarbital—GABRA3—Transmembrane transport of small molecules—GABRQ—attention deficit hyperactivity disorder	0.000199	0.00148	CbGpPWpGaD
Hexobarbital—GABRA3—Transmission across Chemical Synapses—SNAP25—attention deficit hyperactivity disorder	0.000197	0.00147	CbGpPWpGaD
Hexobarbital—GABRA2—Transmembrane transport of small molecules—GABRQ—attention deficit hyperactivity disorder	0.000195	0.00146	CbGpPWpGaD
Hexobarbital—GABRA2—Transmission across Chemical Synapses—SNAP25—attention deficit hyperactivity disorder	0.000194	0.00145	CbGpPWpGaD
Hexobarbital—GABRA5—Neuronal System—CACNB2—attention deficit hyperactivity disorder	0.000193	0.00144	CbGpPWpGaD
Hexobarbital—CHRNA7—Neuronal System—COMT—attention deficit hyperactivity disorder	0.00019	0.00142	CbGpPWpGaD
Hexobarbital—GABRA3—Neuronal System—CACNB2—attention deficit hyperactivity disorder	0.000189	0.00141	CbGpPWpGaD
Hexobarbital—CHRNA7—Neuronal System—MAOA—attention deficit hyperactivity disorder	0.000189	0.00141	CbGpPWpGaD
Hexobarbital—GABRA6—Neuronal System—CHRNA4—attention deficit hyperactivity disorder	0.000189	0.00141	CbGpPWpGaD
Hexobarbital—GRIA2—Neuronal System—SLC6A3—attention deficit hyperactivity disorder	0.000188	0.0014	CbGpPWpGaD
Hexobarbital—GABRA4—Neuronal System—CHRNA4—attention deficit hyperactivity disorder	0.000186	0.00139	CbGpPWpGaD
Hexobarbital—GABRA2—Neuronal System—CACNB2—attention deficit hyperactivity disorder	0.000186	0.00139	CbGpPWpGaD
Hexobarbital—CHRNA4—Neuronal System—SLC6A3—attention deficit hyperactivity disorder	0.000182	0.00136	CbGpPWpGaD
Hexobarbital—GABRA5—Transmission across Chemical Synapses—SLC6A3—attention deficit hyperactivity disorder	0.000179	0.00134	CbGpPWpGaD
Hexobarbital—GABRA1—Transmission across Chemical Synapses—CHRNA4—attention deficit hyperactivity disorder	0.000178	0.00133	CbGpPWpGaD
Hexobarbital—CYP2E1—Phase 1 - Functionalization of compounds—MAOA—attention deficit hyperactivity disorder	0.000176	0.00131	CbGpPWpGaD
Hexobarbital—GABRA3—Transmission across Chemical Synapses—SLC6A3—attention deficit hyperactivity disorder	0.000176	0.00131	CbGpPWpGaD
Hexobarbital—GABRA6—Neuronal System—SNAP25—attention deficit hyperactivity disorder	0.000175	0.00131	CbGpPWpGaD
Hexobarbital—GABRA1—Transmembrane transport of small molecules—SLC9A9—attention deficit hyperactivity disorder	0.000174	0.0013	CbGpPWpGaD
Hexobarbital—GABRA6—Transmission across Chemical Synapses—COMT—attention deficit hyperactivity disorder	0.000174	0.00129	CbGpPWpGaD
Hexobarbital—GABRA4—Neuronal System—SNAP25—attention deficit hyperactivity disorder	0.000173	0.00129	CbGpPWpGaD
Hexobarbital—GABRA2—Transmission across Chemical Synapses—SLC6A3—attention deficit hyperactivity disorder	0.000173	0.00129	CbGpPWpGaD
Hexobarbital—GABRA6—Transmission across Chemical Synapses—MAOA—attention deficit hyperactivity disorder	0.000172	0.00129	CbGpPWpGaD
Hexobarbital—GABRA4—Transmission across Chemical Synapses—COMT—attention deficit hyperactivity disorder	0.000171	0.00128	CbGpPWpGaD
Hexobarbital—GABRA4—Transmission across Chemical Synapses—MAOA—attention deficit hyperactivity disorder	0.00017	0.00127	CbGpPWpGaD
Hexobarbital—GABRA1—Transmembrane transport of small molecules—GABRQ—attention deficit hyperactivity disorder	0.000166	0.00124	CbGpPWpGaD
Hexobarbital—GABRA5—Neuronal System—CHRNA4—attention deficit hyperactivity disorder	0.000166	0.00124	CbGpPWpGaD
Hexobarbital—GABRA1—Transmission across Chemical Synapses—SNAP25—attention deficit hyperactivity disorder	0.000165	0.00123	CbGpPWpGaD
Hexobarbital—GABRA3—Neuronal System—CHRNA4—attention deficit hyperactivity disorder	0.000163	0.00121	CbGpPWpGaD
Hexobarbital—GRIA2—Neuronal System—COMT—attention deficit hyperactivity disorder	0.00016	0.00119	CbGpPWpGaD
Hexobarbital—GABRA2—Neuronal System—CHRNA4—attention deficit hyperactivity disorder	0.00016	0.00119	CbGpPWpGaD
Hexobarbital—GRIA2—Neuronal System—MAOA—attention deficit hyperactivity disorder	0.000159	0.00118	CbGpPWpGaD
Hexobarbital—GABRA1—Neuronal System—CACNB2—attention deficit hyperactivity disorder	0.000158	0.00118	CbGpPWpGaD
Hexobarbital—GABRA6—Neuronal System—SLC6A3—attention deficit hyperactivity disorder	0.000156	0.00117	CbGpPWpGaD
Hexobarbital—CHRNA4—Neuronal System—COMT—attention deficit hyperactivity disorder	0.000155	0.00116	CbGpPWpGaD
Hexobarbital—GABRA4—Neuronal System—SLC6A3—attention deficit hyperactivity disorder	0.000154	0.00115	CbGpPWpGaD
Hexobarbital—CHRNA4—Neuronal System—MAOA—attention deficit hyperactivity disorder	0.000154	0.00115	CbGpPWpGaD
Hexobarbital—GABRA5—Neuronal System—SNAP25—attention deficit hyperactivity disorder	0.000154	0.00115	CbGpPWpGaD
Hexobarbital—GABRA5—Transmission across Chemical Synapses—COMT—attention deficit hyperactivity disorder	0.000152	0.00114	CbGpPWpGaD
Hexobarbital—GABRA1—SIDS Susceptibility Pathways—MAOA—attention deficit hyperactivity disorder	0.000152	0.00113	CbGpPWpGaD
Hexobarbital—GABRA5—Transmission across Chemical Synapses—MAOA—attention deficit hyperactivity disorder	0.000151	0.00113	CbGpPWpGaD
Hexobarbital—GABRA3—Neuronal System—SNAP25—attention deficit hyperactivity disorder	0.000151	0.00113	CbGpPWpGaD
Hexobarbital—GABRA3—Transmission across Chemical Synapses—COMT—attention deficit hyperactivity disorder	0.000149	0.00112	CbGpPWpGaD
Hexobarbital—GABRA2—Neuronal System—SNAP25—attention deficit hyperactivity disorder	0.000149	0.00111	CbGpPWpGaD
Hexobarbital—GABRA3—Transmission across Chemical Synapses—MAOA—attention deficit hyperactivity disorder	0.000148	0.00111	CbGpPWpGaD
Hexobarbital—GABRA1—Transmission across Chemical Synapses—SLC6A3—attention deficit hyperactivity disorder	0.000147	0.0011	CbGpPWpGaD
Hexobarbital—GABRA2—Transmission across Chemical Synapses—COMT—attention deficit hyperactivity disorder	0.000147	0.0011	CbGpPWpGaD
Hexobarbital—GABRA1—SIDS Susceptibility Pathways—BDNF—attention deficit hyperactivity disorder	0.000146	0.00109	CbGpPWpGaD
Hexobarbital—GABRA2—Transmission across Chemical Synapses—MAOA—attention deficit hyperactivity disorder	0.000146	0.00109	CbGpPWpGaD
Hexobarbital—GABRA5—Neuronal System—SLC6A3—attention deficit hyperactivity disorder	0.000137	0.00102	CbGpPWpGaD
Hexobarbital—GABRA1—Neuronal System—CHRNA4—attention deficit hyperactivity disorder	0.000136	0.00102	CbGpPWpGaD
Hexobarbital—CYP2C19—Phase 1 - Functionalization of compounds—MAOA—attention deficit hyperactivity disorder	0.000136	0.00101	CbGpPWpGaD
Hexobarbital—GABRA3—Neuronal System—SLC6A3—attention deficit hyperactivity disorder	0.000135	0.001	CbGpPWpGaD
Hexobarbital—GABRA6—Neuronal System—COMT—attention deficit hyperactivity disorder	0.000133	0.000992	CbGpPWpGaD
Hexobarbital—GABRA2—Neuronal System—SLC6A3—attention deficit hyperactivity disorder	0.000132	0.000988	CbGpPWpGaD
Hexobarbital—GABRA6—Neuronal System—MAOA—attention deficit hyperactivity disorder	0.000132	0.000985	CbGpPWpGaD
Hexobarbital—GABRA4—Neuronal System—COMT—attention deficit hyperactivity disorder	0.000131	0.000979	CbGpPWpGaD
Hexobarbital—GABRA4—Neuronal System—MAOA—attention deficit hyperactivity disorder	0.00013	0.000972	CbGpPWpGaD
Hexobarbital—CHRNA7—SIDS Susceptibility Pathways—EP300—attention deficit hyperactivity disorder	0.00013	0.000969	CbGpPWpGaD
Hexobarbital—GABRA1—Neuronal System—SNAP25—attention deficit hyperactivity disorder	0.000127	0.000945	CbGpPWpGaD
Hexobarbital—PTGS1—Biological oxidations—COMT—attention deficit hyperactivity disorder	0.000126	0.00094	CbGpPWpGaD
Hexobarbital—GABRA1—Transmission across Chemical Synapses—COMT—attention deficit hyperactivity disorder	0.000125	0.000935	CbGpPWpGaD
Hexobarbital—PTGS1—Biological oxidations—MAOA—attention deficit hyperactivity disorder	0.000125	0.000933	CbGpPWpGaD
Hexobarbital—GABRA1—Transmission across Chemical Synapses—MAOA—attention deficit hyperactivity disorder	0.000124	0.000928	CbGpPWpGaD
Hexobarbital—CYP2C9—Phase 1 - Functionalization of compounds—MAOA—attention deficit hyperactivity disorder	0.000124	0.000924	CbGpPWpGaD
Hexobarbital—GABRA1—SIDS Susceptibility Pathways—HTR2A—attention deficit hyperactivity disorder	0.000124	0.000923	CbGpPWpGaD
Hexobarbital—GABRA5—Neuronal System—COMT—attention deficit hyperactivity disorder	0.000117	0.00087	CbGpPWpGaD
Hexobarbital—GABRA5—Neuronal System—MAOA—attention deficit hyperactivity disorder	0.000116	0.000864	CbGpPWpGaD
Hexobarbital—GABRA3—Neuronal System—COMT—attention deficit hyperactivity disorder	0.000115	0.000855	CbGpPWpGaD
Hexobarbital—GABRA3—Neuronal System—MAOA—attention deficit hyperactivity disorder	0.000114	0.000848	CbGpPWpGaD
Hexobarbital—GABRA1—Neuronal System—SLC6A3—attention deficit hyperactivity disorder	0.000113	0.000842	CbGpPWpGaD
Hexobarbital—GABRA2—Neuronal System—COMT—attention deficit hyperactivity disorder	0.000113	0.00084	CbGpPWpGaD
Hexobarbital—GABRA2—Neuronal System—MAOA—attention deficit hyperactivity disorder	0.000112	0.000834	CbGpPWpGaD
Hexobarbital—CHRNA4—SIDS Susceptibility Pathways—EP300—attention deficit hyperactivity disorder	0.000106	0.00079	CbGpPWpGaD
Hexobarbital—CYP1A2—Phase 1 - Functionalization of compounds—MAOA—attention deficit hyperactivity disorder	0.000106	0.000789	CbGpPWpGaD
Hexobarbital—CYP1A2—Phase II conjugation—COMT—attention deficit hyperactivity disorder	9.67e-05	0.000722	CbGpPWpGaD
Hexobarbital—GABRA1—Neuronal System—COMT—attention deficit hyperactivity disorder	9.6e-05	0.000716	CbGpPWpGaD
Hexobarbital—GABRA1—Neuronal System—MAOA—attention deficit hyperactivity disorder	9.53e-05	0.000711	CbGpPWpGaD
Hexobarbital—CYP2E1—Biological oxidations—COMT—attention deficit hyperactivity disorder	9.41e-05	0.000702	CbGpPWpGaD
Hexobarbital—CYP2E1—Biological oxidations—MAOA—attention deficit hyperactivity disorder	9.35e-05	0.000697	CbGpPWpGaD
Hexobarbital—CYP2E1—Metapathway biotransformation—COMT—attention deficit hyperactivity disorder	9.28e-05	0.000693	CbGpPWpGaD
Hexobarbital—GABRA6—Transmembrane transport of small molecules—SLC6A3—attention deficit hyperactivity disorder	8.41e-05	0.000627	CbGpPWpGaD
Hexobarbital—GABRA4—Transmembrane transport of small molecules—SLC6A3—attention deficit hyperactivity disorder	8.3e-05	0.000619	CbGpPWpGaD
Hexobarbital—CYP3A4—Phase 1 - Functionalization of compounds—MAOA—attention deficit hyperactivity disorder	8.16e-05	0.000609	CbGpPWpGaD
Hexobarbital—GABRA5—Transmembrane transport of small molecules—SLC6A3—attention deficit hyperactivity disorder	7.38e-05	0.00055	CbGpPWpGaD
Hexobarbital—CYP2C19—Biological oxidations—COMT—attention deficit hyperactivity disorder	7.26e-05	0.000542	CbGpPWpGaD
Hexobarbital—GABRA3—Transmembrane transport of small molecules—SLC6A3—attention deficit hyperactivity disorder	7.24e-05	0.00054	CbGpPWpGaD
Hexobarbital—CYP2C19—Biological oxidations—MAOA—attention deficit hyperactivity disorder	7.21e-05	0.000538	CbGpPWpGaD
Hexobarbital—CYP2C19—Metapathway biotransformation—COMT—attention deficit hyperactivity disorder	7.16e-05	0.000534	CbGpPWpGaD
Hexobarbital—GABRA2—Transmembrane transport of small molecules—SLC6A3—attention deficit hyperactivity disorder	7.12e-05	0.000531	CbGpPWpGaD
Hexobarbital—CYP1A2—Aryl Hydrocarbon Receptor—EP300—attention deficit hyperactivity disorder	6.97e-05	0.00052	CbGpPWpGaD
Hexobarbital—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EP300—attention deficit hyperactivity disorder	6.97e-05	0.00052	CbGpPWpGaD
Hexobarbital—CYP2C9—Biological oxidations—COMT—attention deficit hyperactivity disorder	6.62e-05	0.000494	CbGpPWpGaD
Hexobarbital—CYP2C9—Biological oxidations—MAOA—attention deficit hyperactivity disorder	6.58e-05	0.000491	CbGpPWpGaD
Hexobarbital—GABRA1—SIDS Susceptibility Pathways—EP300—attention deficit hyperactivity disorder	6.55e-05	0.000489	CbGpPWpGaD
Hexobarbital—CYP2C9—Metapathway biotransformation—COMT—attention deficit hyperactivity disorder	6.53e-05	0.000487	CbGpPWpGaD
Hexobarbital—GABRA1—Transmembrane transport of small molecules—SLC6A3—attention deficit hyperactivity disorder	6.07e-05	0.000453	CbGpPWpGaD
Hexobarbital—CYP1A2—Biological oxidations—COMT—attention deficit hyperactivity disorder	5.66e-05	0.000422	CbGpPWpGaD
Hexobarbital—CYP1A2—Biological oxidations—MAOA—attention deficit hyperactivity disorder	5.62e-05	0.000419	CbGpPWpGaD
Hexobarbital—CYP1A2—Metapathway biotransformation—COMT—attention deficit hyperactivity disorder	5.58e-05	0.000416	CbGpPWpGaD
Hexobarbital—PTGS1—Metabolism—ADRA2C—attention deficit hyperactivity disorder	5.15e-05	0.000384	CbGpPWpGaD
Hexobarbital—CYP3A4—Biological oxidations—COMT—attention deficit hyperactivity disorder	4.37e-05	0.000326	CbGpPWpGaD
Hexobarbital—CYP3A4—Biological oxidations—MAOA—attention deficit hyperactivity disorder	4.34e-05	0.000324	CbGpPWpGaD
Hexobarbital—CYP3A4—Metapathway biotransformation—COMT—attention deficit hyperactivity disorder	4.31e-05	0.000321	CbGpPWpGaD
Hexobarbital—CYP2E1—Metabolism—ADRA2C—attention deficit hyperactivity disorder	3.85e-05	0.000287	CbGpPWpGaD
Hexobarbital—PTGS1—Metabolism—TPH2—attention deficit hyperactivity disorder	3.56e-05	0.000265	CbGpPWpGaD
Hexobarbital—PTGS1—Metabolism—CACNB2—attention deficit hyperactivity disorder	3.56e-05	0.000265	CbGpPWpGaD
Hexobarbital—PTGS1—Metabolism—DPYD—attention deficit hyperactivity disorder	3.5e-05	0.000261	CbGpPWpGaD
Hexobarbital—PTGS1—Metabolism—CACNA1C—attention deficit hyperactivity disorder	3.25e-05	0.000243	CbGpPWpGaD
Hexobarbital—CYP2C19—Metabolism—ADRA2C—attention deficit hyperactivity disorder	2.97e-05	0.000222	CbGpPWpGaD
Hexobarbital—PTGS1—Metabolism—SNAP25—attention deficit hyperactivity disorder	2.84e-05	0.000212	CbGpPWpGaD
Hexobarbital—CYP2C9—Metabolism—ADRA2C—attention deficit hyperactivity disorder	2.71e-05	0.000202	CbGpPWpGaD
Hexobarbital—PTGS1—Metabolism—ADRA2A—attention deficit hyperactivity disorder	2.71e-05	0.000202	CbGpPWpGaD
Hexobarbital—CYP2E1—Metabolism—TPH2—attention deficit hyperactivity disorder	2.66e-05	0.000198	CbGpPWpGaD
Hexobarbital—CYP2E1—Metabolism—CACNB2—attention deficit hyperactivity disorder	2.66e-05	0.000198	CbGpPWpGaD
Hexobarbital—CYP2E1—Metabolism—DPYD—attention deficit hyperactivity disorder	2.61e-05	0.000195	CbGpPWpGaD
Hexobarbital—CYP2E1—Metabolism—CACNA1C—attention deficit hyperactivity disorder	2.43e-05	0.000181	CbGpPWpGaD
Hexobarbital—CYP1A2—Metabolism—ADRA2C—attention deficit hyperactivity disorder	2.31e-05	0.000173	CbGpPWpGaD
Hexobarbital—PTGS1—Metabolism—COMT—attention deficit hyperactivity disorder	2.15e-05	0.000161	CbGpPWpGaD
Hexobarbital—PTGS1—Metabolism—MAOA—attention deficit hyperactivity disorder	2.14e-05	0.00016	CbGpPWpGaD
Hexobarbital—CYP2E1—Metabolism—SNAP25—attention deficit hyperactivity disorder	2.12e-05	0.000158	CbGpPWpGaD
Hexobarbital—PTGS1—Metabolism of lipids and lipoproteins—EP300—attention deficit hyperactivity disorder	2.07e-05	0.000155	CbGpPWpGaD
Hexobarbital—CYP2C19—Metabolism—TPH2—attention deficit hyperactivity disorder	2.05e-05	0.000153	CbGpPWpGaD
Hexobarbital—CYP2C19—Metabolism—CACNB2—attention deficit hyperactivity disorder	2.05e-05	0.000153	CbGpPWpGaD
Hexobarbital—CYP2E1—Metabolism—ADRA2A—attention deficit hyperactivity disorder	2.02e-05	0.000151	CbGpPWpGaD
Hexobarbital—CYP2C19—Metabolism—DPYD—attention deficit hyperactivity disorder	2.02e-05	0.00015	CbGpPWpGaD
Hexobarbital—CYP2C19—Metabolism—CACNA1C—attention deficit hyperactivity disorder	1.88e-05	0.00014	CbGpPWpGaD
Hexobarbital—CYP2C9—Metabolism—TPH2—attention deficit hyperactivity disorder	1.87e-05	0.000139	CbGpPWpGaD
Hexobarbital—CYP2C9—Metabolism—CACNB2—attention deficit hyperactivity disorder	1.87e-05	0.000139	CbGpPWpGaD
Hexobarbital—CYP2C9—Metabolism—DPYD—attention deficit hyperactivity disorder	1.84e-05	0.000137	CbGpPWpGaD
Hexobarbital—CYP3A4—Metabolism—ADRA2C—attention deficit hyperactivity disorder	1.79e-05	0.000133	CbGpPWpGaD
Hexobarbital—CYP2C9—Metabolism—CACNA1C—attention deficit hyperactivity disorder	1.71e-05	0.000128	CbGpPWpGaD
Hexobarbital—CYP2C19—Metabolism—SNAP25—attention deficit hyperactivity disorder	1.64e-05	0.000122	CbGpPWpGaD
Hexobarbital—CYP2E1—Metabolism—COMT—attention deficit hyperactivity disorder	1.61e-05	0.00012	CbGpPWpGaD
Hexobarbital—CYP2E1—Metabolism—MAOA—attention deficit hyperactivity disorder	1.6e-05	0.000119	CbGpPWpGaD
Hexobarbital—CYP1A2—Metabolism—TPH2—attention deficit hyperactivity disorder	1.6e-05	0.000119	CbGpPWpGaD
Hexobarbital—CYP1A2—Metabolism—CACNB2—attention deficit hyperactivity disorder	1.6e-05	0.000119	CbGpPWpGaD
Hexobarbital—CYP1A2—Metabolism—DPYD—attention deficit hyperactivity disorder	1.57e-05	0.000117	CbGpPWpGaD
Hexobarbital—CYP2C19—Metabolism—ADRA2A—attention deficit hyperactivity disorder	1.56e-05	0.000116	CbGpPWpGaD
Hexobarbital—CYP2C9—Metabolism—SNAP25—attention deficit hyperactivity disorder	1.49e-05	0.000111	CbGpPWpGaD
Hexobarbital—CYP1A2—Metabolism—CACNA1C—attention deficit hyperactivity disorder	1.46e-05	0.000109	CbGpPWpGaD
Hexobarbital—CYP2C9—Metabolism—ADRA2A—attention deficit hyperactivity disorder	1.42e-05	0.000106	CbGpPWpGaD
Hexobarbital—CYP1A2—Metabolism—SNAP25—attention deficit hyperactivity disorder	1.28e-05	9.53e-05	CbGpPWpGaD
Hexobarbital—CYP2C19—Metabolism—COMT—attention deficit hyperactivity disorder	1.24e-05	9.27e-05	CbGpPWpGaD
Hexobarbital—CYP2C19—Metabolism—MAOA—attention deficit hyperactivity disorder	1.23e-05	9.2e-05	CbGpPWpGaD
Hexobarbital—CYP3A4—Metabolism—CACNB2—attention deficit hyperactivity disorder	1.23e-05	9.2e-05	CbGpPWpGaD
Hexobarbital—CYP3A4—Metabolism—TPH2—attention deficit hyperactivity disorder	1.23e-05	9.2e-05	CbGpPWpGaD
Hexobarbital—CYP1A2—Metabolism—ADRA2A—attention deficit hyperactivity disorder	1.22e-05	9.07e-05	CbGpPWpGaD
Hexobarbital—CYP3A4—Metabolism—DPYD—attention deficit hyperactivity disorder	1.21e-05	9.05e-05	CbGpPWpGaD
Hexobarbital—CYP2C19—Metabolism of lipids and lipoproteins—EP300—attention deficit hyperactivity disorder	1.2e-05	8.92e-05	CbGpPWpGaD
Hexobarbital—CYP2C9—Metabolism—COMT—attention deficit hyperactivity disorder	1.13e-05	8.45e-05	CbGpPWpGaD
Hexobarbital—CYP3A4—Metabolism—CACNA1C—attention deficit hyperactivity disorder	1.13e-05	8.41e-05	CbGpPWpGaD
Hexobarbital—CYP2C9—Metabolism—MAOA—attention deficit hyperactivity disorder	1.12e-05	8.39e-05	CbGpPWpGaD
Hexobarbital—CYP2C9—Metabolism of lipids and lipoproteins—EP300—attention deficit hyperactivity disorder	1.09e-05	8.14e-05	CbGpPWpGaD
Hexobarbital—CYP3A4—Metabolism—SNAP25—attention deficit hyperactivity disorder	9.86e-06	7.35e-05	CbGpPWpGaD
Hexobarbital—CYP1A2—Metabolism—COMT—attention deficit hyperactivity disorder	9.68e-06	7.22e-05	CbGpPWpGaD
Hexobarbital—CYP1A2—Metabolism—MAOA—attention deficit hyperactivity disorder	9.61e-06	7.17e-05	CbGpPWpGaD
Hexobarbital—CYP3A4—Metabolism—ADRA2A—attention deficit hyperactivity disorder	9.38e-06	7e-05	CbGpPWpGaD
Hexobarbital—CYP1A2—Metabolism of lipids and lipoproteins—EP300—attention deficit hyperactivity disorder	9.32e-06	6.95e-05	CbGpPWpGaD
Hexobarbital—PTGS1—Metabolism—EP300—attention deficit hyperactivity disorder	9.24e-06	6.89e-05	CbGpPWpGaD
Hexobarbital—CYP3A4—Metabolism—COMT—attention deficit hyperactivity disorder	7.47e-06	5.57e-05	CbGpPWpGaD
Hexobarbital—CYP3A4—Metabolism—MAOA—attention deficit hyperactivity disorder	7.42e-06	5.53e-05	CbGpPWpGaD
Hexobarbital—CYP2E1—Metabolism—EP300—attention deficit hyperactivity disorder	6.9e-06	5.15e-05	CbGpPWpGaD
Hexobarbital—CYP2C19—Metabolism—EP300—attention deficit hyperactivity disorder	5.33e-06	3.97e-05	CbGpPWpGaD
Hexobarbital—CYP2C9—Metabolism—EP300—attention deficit hyperactivity disorder	4.86e-06	3.62e-05	CbGpPWpGaD
Hexobarbital—CYP1A2—Metabolism—EP300—attention deficit hyperactivity disorder	4.15e-06	3.1e-05	CbGpPWpGaD
Hexobarbital—CYP3A4—Metabolism—EP300—attention deficit hyperactivity disorder	3.2e-06	2.39e-05	CbGpPWpGaD
